A CLINICAL INVESTIGATION OF SEVEN PATIENTS WITH PULMONARY TUBERCULOSIS WHO DEVELOPED MIXED LIVER INJURY DURING ORAL ANTI-TUBERCULOSIS TREATMENT

[Background] Liver injury is the most common and clinically significant adverse reaction to anti-tuberculosis drugs, sometimes resulting in a fatal outcome. It has been reported that liver injury induced by isoniazid and pyrazinamide, which has the potential to cause hepatocellular injury, has a ris...

Ausführliche Beschreibung